Pelvic inflammatory disease. Inflammatory disease of uterus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Accompanied by standard antibiotics therapy participants are prescribed suppository rectal distreptaza 2g for 9 days,(3 days,TDS, 3days BD,3 days daily) , after whi
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: All patients by pelvic pain and discomfort less than 30 days Pelvic tenderness in vaginal examination Mucoprulant cervicite Absence of pregnancy
Exclusion criteria
Exclusion criteria: Urinary tract infection Tuboovarian abscesses Endometriosis Appendicitis Diverticulitis Hemorrhagic ovarian cyst Ovarian torsion IUD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post infection adhisions. Timepoint: Two weeks after intervention. Method of measurement: By transvaginal sonogram.;Vaginal infection. Timepoint: Two weeks after intervention. Method of measurement: By vaginal examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Davari Tanha
Tehran University of Medical Sciences
Outcome results
None listed